---
figid: PMC7069124__fbioe-08-00074-g004
figtitle: 'Overlaying the consensus TLR4 signaling pathway in databases with HemeKG
  (A: original overlaid network, B: overlaid network after inclusion of literature
  evidence for effectors)'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Danio rerio
pmcid: PMC7069124
filename: fbioe-08-00074-g004.jpg
figlink: pmc/articles/PMC7069124/figure/F4/
number: F4
caption: 'Overlaying the consensus TLR4 signaling pathway in databases with HemeKG
  (A: original overlaid network, B: overlaid network after inclusion of literature
  evidence for effectors). The orange colored boxes display the common effector molecules
  between the canonical TLR4 signaling pathway and induced TLR4 signaling pathway
  stimulated by labile heme. Heme/TLR4 activates the adaptor molecule MyD88. Activated
  MyD88 promotes the degradation of NFKBIA (NF-κB inhibitor α) through phosphorylation
  of the IKK complex (inhibitor of nuclear factor κB kinase complex), thus promoting
  NF-κB (nuclear factor κ-light-chain-enhancer of activated B cells) and MAPKs (mitogen-activated
  protein kinases) stimulation leading to the secretion of TNF-α, IL6, IL1B and KC
  (keratinocyte-derived chemokine) (; ). The TRIF (Toll-like receptor adaptor molecule
  1) dependent pathway is activated upon signaling of heme through TLR4 leading to
  the activation of IRF3 (interferon regulatory factor 3) stimulating the secretion
  of interferons (i.e., IFN-α) and CXCL10 (C-X-C motif chemokine ligand 10) (). However,
  the activation profiles for IRAK1/2, TRAF6, TRAM, TRAF3, TBK1/IKK epsilon complex
  and IRF7 are not yet studied for heme-TLR4 signaling pathway.'
papertitle: A Computational Approach for Mapping Heme Biology in the Context of Hemolytic
  Disorders.
reftext: Farah Humayun, et al. Front Bioeng Biotechnol. 2020;8:74.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8112821
figid_alias: PMC7069124__F4
figtype: Figure
redirect_from: /figures/PMC7069124__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7069124__fbioe-08-00074-g004.html
  '@type': Dataset
  description: 'Overlaying the consensus TLR4 signaling pathway in databases with
    HemeKG (A: original overlaid network, B: overlaid network after inclusion of literature
    evidence for effectors). The orange colored boxes display the common effector
    molecules between the canonical TLR4 signaling pathway and induced TLR4 signaling
    pathway stimulated by labile heme. Heme/TLR4 activates the adaptor molecule MyD88.
    Activated MyD88 promotes the degradation of NFKBIA (NF-κB inhibitor α) through
    phosphorylation of the IKK complex (inhibitor of nuclear factor κB kinase complex),
    thus promoting NF-κB (nuclear factor κ-light-chain-enhancer of activated B cells)
    and MAPKs (mitogen-activated protein kinases) stimulation leading to the secretion
    of TNF-α, IL6, IL1B and KC (keratinocyte-derived chemokine) (; ). The TRIF (Toll-like
    receptor adaptor molecule 1) dependent pathway is activated upon signaling of
    heme through TLR4 leading to the activation of IRF3 (interferon regulatory factor
    3) stimulating the secretion of interferons (i.e., IFN-α) and CXCL10 (C-X-C motif
    chemokine ligand 10) (). However, the activation profiles for IRAK1/2, TRAF6,
    TRAM, TRAF3, TBK1/IKK epsilon complex and IRF7 are not yet studied for heme-TLR4
    signaling pathway.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Inpp5d
  - Irak3
  - Tnf
  - .na.character
  - Ikbkg
  - Cd14
  - Il1b
  - Tab1
  - Ikbkb
  - Nfkb1
  - Il6
  - Chuk
  - Tab2
  - Tab3
  - Nfkbia
  - Tirap
  - Irak4
  - Traf6
  - Tlr4
  - Myd88
  - Nr2c2
  - Map3k7
  - Irak1
  - Nedd9
  - Scyl1
  - Irak2
  - Cd40
  - Cd80
  - Map3k8
  - Map2
  - Man2a1
  - Neu1
  - Map2k1
  - Jun
  - Tmed7
  - Ticam2
  - Map2k3
  - Map6
  - Ralbp1
  - Ripk1
  - Cd86
  - Map7
  - Map2k4
  - Apk
  - Mapk8
  - Ifna
  - Irf7
  - Ifnb1
  - Cxcl9
  - Cxcl10
  - Ikbke
  - Irf3
  - Rnf138
  - Trim69
  - Ticam1
  - Tbk1
  - Traf3
  - Cxcl11
  - Mapk1
  - INPP5D
  - IRAK3
  - TNF
  - IKBKG
  - CD14
  - NDUFA2
  - IL1B
  - TAB1
  - IKBKB
  - NFKB1
  - IL6
  - CHUK
  - TAB2
  - TAB3
  - NFKBIA
  - IKBKE
  - TBK1
  - IL12A
  - IL12B
  - TIRAP
  - IRAK4
  - TRAF6
  - TLR4
  - MYD88
  - MAP3K7
  - NR2C2
  - IRAK1
  - CDH13
  - SCYL1
  - IRAK2
  - CD40
  - CD80
  - MAP3K8
  - MAP2
  - MASP2
  - METAP2
  - MAP4
  - MAPT
  - MAP2K1
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - TRAM1
  - TICAM2
  - TMED7-TICAM2
  - MAP2K3
  - MAP6
  - UQCRFS1
  - RIPK1
  - RALBP1
  - KRR1
  - CD86
  - MAP7
  - MAP2K4
  - MAPK8
  - IFNA1
  - CXCL8
  - IRF7
  - IFNB1
  - CXCL9
  - CXCL10
  - IRF3
  - TRIM69
  - TICAM1
  - TRAF3
  - CXCL11
  - MAPK1
  - Il12b
  - Mapk3
  - inpp5d
  - irak3
  - tnfrsfa
  - tnfb
  - ikbkg
  - il1b
  - tab1
  - ikbkb
  - il6
  - chuk
  - tab2
  - tab3
  - nfkbiab
  - tirap
  - irak4
  - traf6
  - myd88
  - irak1
  - cd40
  - map2
  - map2k1
  - tram1
  - map2k6
  - map6a
  - ripk1l
  - map7b
  - map2k4a
  - mapk8b
  - cxcl8a
  - irf7
  - irf3
  - ticam1
  - tbk1
  - traf3
  - cxcl11.7
  - mapk1
---
